Skip to Content

News: Research

Grant to help address complexity of cancer care

Wednesday, January 16th, 2019

Study identifies novel genetic factors for colorectal cancer risk

Wednesday, January 16th, 2019

The exocyst dynamo

Friday, December 14th, 2018

A recent study in Nature Communications reveals new insights about the function of the exocyst – a crucial cellular protein complex involved in vesicle trafficking.

Breast cancer-killing RIG

Friday, December 14th, 2018

A recent study in the journal Cancer Research demonstrates that a RIG-I agonist has potent immunogenic and therapeutic effects in breast cancer.

RNA processing and antiviral immunity

Friday, December 14th, 2018

A recent study in Nature Communications defines the in vivo substrates of RIG-I like receptors (RLRs) during an oncogenic virus infection and reveals a relationship between cellular RNA processing and an innate antiviral immune response.

Berkeley’s Bissell highlights Retreat for Cancer Research

Friday, December 14th, 2018

Mina Bissell, PhD, gave an overview of her career at the 18th Annual Retreat for Cancer Research, detailing how she basically followed her nose to become an acclaimed scientist.

Study tests new vaccine for precancerous cervical cells

Wednesday, December 12th, 2018

Vanderbilt University Medical Center is participating in an international study to determine the effectiveness of a new therapeutic vaccine for treating women with precancerous changes on the cervix.

Vanderbilt Biophotonics Center collaboration seeks earlier diagnosis of throat cancer

Saturday, December 1st, 2018

Researchers in the schools of engineering and medicine are exploring the use of Raman spectroscopy for early detection of HPV-related cancers of the throat in order to reduce the need for biopsies and to offer less intensive therapies.

Lung cancer survival signal

Saturday, December 1st, 2018

A recent study shows that a cell receptor, SSTR2, is a candidate biomarker for poor prognosis and a potential therapeutic target for small cell lung cancer.

Immunotherapies linked to specific heart complications

Tuesday, November 20th, 2018

Cardiovascular complications linked to immune checkpoint inhibitors include myocarditis, pericarditis, vasculitis and arrhythmias and occur early in the course of treatment, Vanderbilt researchers report.

Next Page »